Balance Sheet

Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

Celularity (CELU) Amortization of Goodwill (2022 - 2023)

Celularity (CELU) has disclosed Amortization of Goodwill for 2 consecutive years, with $82.7 million as the latest value for Q3 2023.

For Q3 2023, Amortization of Goodwill changed N/A year-over-year to $82.7 million; the TTM value through Jun 2024 reached $82.7 million, up 148.82%, while the annual FY2023 figure was $112.3 million, 3012.11% up from the prior year.
Amortization of Goodwill hit $82.7 million in Q3 2023 for Celularity, up from $29.6 million in the prior quarter.
Across five years, Amortization of Goodwill topped out at $82.7 million in Q3 2023 and bottomed at $3.6 million in Q4 2022.